Tramadol Hydrochloride Tablet, Film Coated
Product Images NDC 87063-117

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 87063-117). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (E43a14b1 3c3c 4d97 A157 E118a29d1800 01)

Image (E43a14b1 3c3c 4d97 A157 E118a29d1800 01)
Chemical structure of Tramadol Hydrochloride showing its molecular arrangement including the cyclohexane ring, methoxyphenyl group, and hydrochloride component.*
FDA Label Image

Image (E43a14b1 3c3c 4d97 A157 E118a29d1800 02)

Image (E43a14b1 3c3c 4d97 A157 E118a29d1800 02)
A pharmacokinetic graph showing the concentration (ng/mL) of Tramadol and its M1 metabolite over time (hours) for single and multiple doses. The graph includes distinct curves for Tramadol single dose and multiple dose, as well as for M1 single dose and multiple dose, demonstrating changes in concentration up to 48 hours.*
FDA Label Image

Figure 2 (E43a14b1 3c3c 4d97 A157 E118a29d1800 03)

Figure 2 (E43a14b1 3c3c 4d97 A157 E118a29d1800 03)
A Kaplan-Meier curve depicting time to discontinuation due to nausea or vomiting in Protocol CAPSS-047. The x-axis represents days in double-blind treatment up to 25 days, and the y-axis shows percent discontinuation. Two lines compare 10 days versus 16 days to 200 mg/day dosing regimens, illustrating differing discontinuation rates over time.*
FDA Label Image

1 (Label)

1 (Label)
Multiple packaging labels for traMADol HCl Tablets, USP 50 mg, film-coated oral tablets by Enovachem Pharmaceuticals and Asclemed USA, Inc. Labels include NDC numbers ranging from 87063-117-01 to 87063-117-90, with varying quantities from 10 to 500 tablets. Each label shows manufacturing details, storage instructions, and a prominent CIV (Schedule IV) drug status marking.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.